The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
Open accessAbstract
Background & aims Liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE) has been shown to predict outcomes of patients with primary biliary cholangitis (PBC) in small-size studies. We aimed to validate the prognostic value of LSM in a large cohort study. Methods We performed an international, multicentre, retrospective follow-up study of 3,985 patients with PBC seen at 23 centres in 12 countries. Eligibility criteria included at least 1 reliable LSM by VCTE and a follow-up ≥ 1 year. Independent derivation (n = 2,740) and validation (n = 568) cohorts were built. The primary endpoint was time to poor clinical outcomes defined as liver-related complications, liver transplantation, or death. Hazard ratios (HRs) with CIs were determined using a time-dependent multivariable Cox regression analysis. Results LSM was independently associated with poor clinical outcomes in the derivation (5,324 LSMs, mean follow-up 5.0 ± 3.1 years) and validation (1,470 LSMs, mean follow-up 5.0 ± 2.8 years) cohorts: adjusted HRs (95% CI) per additional kPa were 1.040 (1.026-1.054) and 1.042 (1.029-1.056), respectively (p <0.0001 for both). Adjusted C-statistics (95% CI) at baseline were 0.83 (0.79-0.87) and 0.92 (0.89-0.95), respectively. Between 5 and 30 kPa, the log-HR increased as a monotonic function of LSM. The predictive value of LSM was stable in time. LSM improved the prognostic ability of biochemical response criteria, fibrosis scores, and prognostic scores. The 8 kPa and 15 kPa cut-offs optimally separated low-, medium-, and high-risk groups. Forty percent of patients were at medium to high risk according to LSM. Conclusions LSM by VCTE is a major, independent, validated predictor of PBC outcome. Its value as a surrogate endpoint for clinical benefit in PBC should be considered. Lay summary Primary biliary cholangitis (PBC) is a chronic autoimmune disease, wherein the body's immune system mistakenly attacks the bile ducts. PBC progresses gradually, so surrogate markers (markers that predict clinically relevant outcomes like the need for a transplant or death long before the event occurs) are often needed to expedite the drug development and approval process. Herein, we show that liver stiffness measurement is a strong predictor of clinical outcomes and could be a useful surrogate endpoint in PBC trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A large multicentre retrospective study involving 3985 patients showed that LSM assessed by vibration-controlled transient elastography provided a better prognostic ability than biochemical response.124”
From Primary biliary cholangitis. (2024) · cites this paper as [124]
Citations
Cites
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
Baveno VII – Renewing consensus in portal hypertension
de Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T., Ripoll, C., Abraldes, J. G., Albillos, A., Baiges, A., Bajaj, J., Bañares, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.022 · Cited by 2,930
Self-citationMalinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
Sandrin, L., Fourquet, B., Hasquenoph, J.-M., Yon, S., Fournier, C., Mal, F., Christidis, C., Ziol, M., Poulet, B., Kazemi, F., et al. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2003.07.001 · Cited by 2,734
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
Self-citationPerformance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis
Friedrich‐Rust, M., Ong, M. F., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S., & Herrmann, E. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.034 · Cited by 1,500
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationSurvival Model Predictive Accuracy and ROC Curves
Heagerty, P. J., & Zheng, Y. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.030814.x · Cited by 1,471
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
Castéra, L., Foucher, J., Bernard, P., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2009) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,157
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509840 · Cited by 1,131
Self-citation
Research works printed but not linked: 1
- Rigamonti, 2019, Liver stiffness dynamics predict survival in patients with primary biliary cholangitis treated with ursodeoxycholic acid, Hepatology, 70, 803A
Cited by
Sorted by citations
Tanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177
Primary biliary cholangitis: Epidemiology, prognosis, and treatment
Trivella, J., John, B. V., & Levy, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000179 · Cited by 159
Ferraioli, G., Barr, R. G., Berzigotti, A., Sporea, I., Wong, V. W., Reiberger, T., Karlas, T., Thiele, M. S., Cardoso, A. C., Ayonrinde, O. T., et al. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.03.013 · Cited by 160
New Treatment Paradigms in Primary Biliary Cholangitis
Levy, C., Manns, M. P., & Hirschfield, G. M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.005 · Cited by 149
Self-citationNoninvasive Assessment of Liver Fibrosis
Castéra, L., Rinella, M. E., & Tsochatzis, E. A. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2403308 · Cited by 120
Corpechot, C., Lemoinne, S., Soret, P.-A., Hansen, B., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Pares, A., Olivas, I., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000529 · Cited by 94
Self-citationDevelopment and Application of an Advanced Biomedical Material‐Silk Sericin
Wang, J., Liu, H., Shi, X., Qin, S., Liu, J., Lv, Q., Liu, J., Li, Q., Wang, Z., & Wang, L. (2024) · Advanced Materials · doi:10.1002/adma.202311593 · Cited by 89
Nevens, F., Trauner, M., & Manns, M. P. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.007 · Cited by 51
Self-citationDynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
Lam, L., Soret, P., Lemoinne, S., Hansen, B. E., Hirschfield, G. M., Gulamhusein, A. F., Montaño‐Loza, A. J., Lytvyak, E., Parés, A. R., Olivas, I., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.035 · Cited by 44
Self-citationUpdate on the role of elastography in liver disease
Ferraioli, G., & Roccarina, D. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221140657 · Cited by 39
Self-citationNon-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
Rinaldi, L., Giorgione, C., Mormone, A., Esposito, F., Rinaldi, M., Berretta, M., Marfella, R., & Romano, C. P. (2023) · Viruses · doi:10.3390/v15081730 · Cited by 44
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones, D. E. J., Beuers, U., Bonder, A., Carbone, M., Culver, E., Dyson, J., Gish, R. G., Hansen, B. E., Hirschfield, G., Jones, R., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000864 · Cited by 38
Self-citationPrimary biliary cholangitis: Personalizing second-line therapies
Levy, C., & Bowlus, C. L. (2024) · Hepatology · doi:10.1097/hep.0000000000001166 · Cited by 39
Semmler, G., López, S. A., Pons, M., Lens, S., Dajti, E., Griemsmann, M., Zanetto, A., Burghart, L., Hametner‐Schreil, S., Hartl, L., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.015 · Cited by 34
Self-citationGupta, V., Sehrawat, T. S., Pinzani, M., & Strazzabosco, M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.07.044 · Cited by 36
New Therapies on the Horizon for Primary Biliary Cholangitis
Tanaka, A. (2023) · Drugs · doi:10.1007/s40265-023-01979-1 · Cited by 33
Huang, W., Peng, Y., & Kang, L. (2024) · Open Research (University of Surrey) · doi:10.1002/viw.20240010 · Cited by 32
Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
van Hooff, M. C., Werner, E., & van der Meer, A. J. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.01.030 · Cited by 32
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
You, H., Duan, W., Li, S., Lv, T., Chen, S., Lu, L., Ma, X., Han, Y., Nan, Y., Xu, X., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00347 · Cited by 35
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13181580 · Cited by 28
Hernández‐Pérez, M., Riado, D., Pena, E., Méndez, C., Pinedo, F., Ramos, P., Castillo, P., Romero, M., Fernández‐Rodríguez, C., & Olveira, A. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18134 · Cited by 23
Wong, Y. J., Lam, L., Soret, P., Lemoinne, S., Hansen, B. E., Hirschfield, G. M., Gulamhusein, A. F., Lytvyak, E., Parés, A. R., Olivas, I., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.09.024 · Cited by 21
Self-citationHegmar, H., Wester, A., Aleman, S., Backman, J., Degerman, E., Ekvall, H., Lund, K., Lundgren, Å., Nasr, P., Shahnavaz, A., et al. (2024) · Liver International · doi:10.1111/liv.15919 · Cited by 21
Effects of CFTR modulator therapies on liver stiffness and bile flow: A single-centre experience
Calvo, P. L., Giugliano, L., Evangelista, A., Bignamini, E., & Pinon, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.006 · Cited by 19
Ding, D., Guo, G., Cui, L., Jia, G., Wang, X., Zhang, M., Tian, S., Zheng, L., Liu, Y., Hu, Y., et al. (2023) · Hepatology International · doi:10.1007/s12072-023-10587-w · Cited by 20
Primary biliary cholangitis and the narrowing gap towards optimal disease control
Cançado, G. G. L., Lleò, A., Levy, C., Trauner, M., & Hirschfield, G. M. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00025-1 · Cited by 20
Self-citationLytvyak, E., Hirschfield, G. M., Shreekumar, D., Wong, Y. J., & Montaño‐Loza, A. J. (2025) · Liver International · doi:10.1111/liv.70190 · Cited by 17
Self-citationMontaño‐Loza, A. J., Lytvyak, E., Hirschfield, G. M., Hansen, B. E., Ebadi, M., Berney, T., Toso, C., Magini, G. M., Villamil, A., Nevens, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.05.010 · Cited by 17
Self-citationRigamonti, C., Cittone, M. G., Manfredi, G. F., De Benedittis, C., Paggi, N., Baorda, F., Di Benedetto, D., Minisini, R., & Pirisi, M. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100952 · Cited by 15
Self-citationGóméz, E., Montero, J. L., Molina, E., Garcı́a-Buey, L., Casado, M., Fuentes, J., Simón, M. Á., Díaz‐González, Á., Jorquera, F., Morillas, R. M., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18004 · Cited by 15
Self-citationLiver stiffness measurement predicts clinical outcomes in autoimmune hepatitis
Olivas, I., Arvaniti, P., Gabeta, S., Torres, S. H., Barrio, M. D., Díaz‐González, Á., Esteban, P. P., Riveiro‐Barciela, M., Mauro, E., Rodríguez‐Tajes, S., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101213 · Cited by 15
Self-citationCarbone, M., Gerussi, A., Cardinale, V., Cazzagon, N., Cossiga, V., Lleò, A., Marrone, G., Marzioni, M., Moschetta, A., Muratori, L., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.002 · Cited by 18
Self-citationDing, D., Jia, G., Cui, L., Liu, Y., Wang, X., Sun, R., Deng, J., Guo, G., Shang, Y., & Han, Y. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.12.024 · Cited by 13
Wiegand, J., Franke, A., Müller, T., Stein, K., Bantel, H., Günther, R., Denk, G., Reuken, P. A., Schattenberg, J. M., Naumann, U., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2382-7720 · Cited by 12
Self-citationRisk Stratification in Primary Biliary Cholangitis
Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175713 · Cited by 11
Prognostic models and autoimmune liver diseases
D’Amato, D., & Carbone, M. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101878 · Cited by 10
Self-citationThe Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine
Men, X., Liu, Y., Zhao, H., Xie, B., Guo, C., Leung, P. S. C., Timilsina, S., Gershwin, M. E., Shang, Y., & Han, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09074-x · Cited by 12
Corpechot, C., Hornus, P., Cals, M., Rinder, P., Marcille, T., Malek, A., Belkacem, K. B., Gaouar, F., Chabane, Y., Corret, P., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101546 · Cited by 11
Self-citationDíaz‐González, Á., Schregel, I., Carballo‐Folgoso, L., Álvarez‐Navascués, C., Frisancho-Morales, E., Miquel, M., Garcı́a-Retortillo, M., Gómez, J., Horta, D., Mateos, B., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101562 · Cited by 8
Self-citationAbbas, N., Smith, R. A., Lytvyak, E., Scraravaglio, M., Halliday, N., Almahroos, A., Eden, N., Lloyd‐Madden, D., Sharma, S., Ferguson, J., et al. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70378 · Cited by 8
Self-citationTransient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today’s World
Jalil, S., Pagadala, M. R., Dunn, N., Blaney, H. L., Elfeki, M. A., Thakral, N., & Singal, A. K. (2025) · Current Hepatology Reports · doi:10.1007/s11901-025-00713-7 · Cited by 8
Roccarina, D., Saffioti, F., Rosselli, M., Marshall, A., Pinzani, M., & Thorburn, D. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100873 · Cited by 8
Self-citationAdvances in clinical detection methods and nanomaterials for autoimmune liver diseases
Chen, J., Zhu, Y., Wang, Q., Ding, J., & Chen, X. (2023) · Nano TransMed · doi:10.1016/j.ntm.2023.100003 · Cited by 8
Terracciani, F., Vincentis, A. D., D’Amato, D., Cristoferi, L., Gerussi, A., Invernizzi, P., Scaravaglio, M., Vanni, E., Campion, D., Morgando, A., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101448 · Cited by 7
Self-citationTana, M. M.-S., & Hirschfield, G. M. (2025) · JAMA · doi:10.1001/jama.2025.20067 · Cited by 7
Self-citationEvaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis
Caines, A., Trudeau, S., & Gordon, S. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2390120 · Cited by 7
Autorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 6
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
Invernizzi, P., Aghemo, A., Calvaruso, V., Lleò, A., Marzioni, M., Piscaglia, F., Rigamonti, C., Gentilucci, U. V., Brillanti, S., Carbone, M., et al. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2601220 · Cited by 6
Self-citationDing, D., Hu, Y., Jia, G., Wang, B., Zheng, L., Deng, J., Sun, R., Wang, X., Guo, G., Cui, L., et al. (2024) · Hepatology International · doi:10.1007/s12072-024-10743-w · Cited by 6
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis
Corpechot, C. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.010 · Cited by 6
Self-citationTanaka, A., Treeprasertsuk, S., Chang, M., Tan, S.-S., Efe, C., Jeong, S., Ma, X., Weltman, M., Isayama, H., & Jia, J. (2025) · Hepatology International · doi:10.1007/s12072-025-10965-6 · Cited by 7
van Hooff, M. C., de Veer, R. C., Werner, E., Beuers, U. H., Drenth, J. P. H., Cuperus, F. J. C., van Hoek, B., Veldt, B. J., Klemt‐Kropp, M., van Meer, S., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003879 · Cited by 7
Self-citationLevy, C., Lleo, A., Martins, A., Scaravaglio, M., Bowlus, C. L., Carbone, M., Corpechot, C., Couto, C. A., Hansen, B. E., Hirschfield, G. M., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.03.038 · Cited by 9
Self-citationChe, L., Jiang, R., Wang, C., He, J., Zhang, Z. J., & Qian, B. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002680 · Cited by 5
Biris, A. I., Karamatzanis, I., Biri, D., Biris, I. A., & Maravegias, N. (2024) · Cureus · doi:10.7759/cureus.72087 · Cited by 5
Rigopoulou, E. I., Lygoura, V., Gabeta, S., Gatselis, N., Giannoulis, G., & Dalekos, G. Ν. (2025) · Liver International · doi:10.1111/liv.70074 · Cited by 5
Self-citationAdvancing care in primary biliary cholangitis: emerging insights and novel therapies
Vögelin, M., & Kremer, A. E. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2516622 · Cited by 5
Self-citationShen, Y. G., Chen, H., Wu, S., & Jiang, W. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.013 · Cited by 5
Werner, E., van Hooff, M. C., Weijsters, G. H. X., Abbas, N., Gerussi, A., Willemse, J., Mitchell-Thain, R., Leburgue, A., Hirschfield, G. M., Corpechot, C., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.01.037 · Cited by 5
Self-citationPrimary cilium‐mediated signaling cascade suppresses age‐related biliary fibrosis
Hong, R., Tian, X., Ma, H., Ni, H., Yang, J. N., Bu, W., Li, T., Yang, S., Li, D., Liu, M., et al. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31113 · Cited by 4
Pharmacologic Treatment of Portal Hypertension
Wong, Y. J., & Abraldeṣ, J. G. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.03.002 · Cited by 4
Optimizing treatment of primary biliary cholangitis: Is good, good enough?
Bowlus, C. L., & Levy, C. (2023) · Hepatology · doi:10.1097/hep.0000000000000556 · Cited by 4
Díaz‐González, Á., Molera, C., Domínguez, E. G., Muñoz‐Bartolo, G., Ampuero, J., Fernández‐Rodríguez, C., Quintero, J., Molina, E., Salcedo, M., Olveira, A., et al. (2025) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2026.502629 · Cited by 3
Liu, Z., Jiang, H., Li, F., Xie, R., & Wang, H. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70189 · Cited by 3
Werner, E., van Hooff, M. C., Weijsters, G. H. X., van de Vrie, M. A., de Veer, R. C., Beuers, U. H., Drenth, J. P. H., Cuperus, F. J. C., van Dijk, R., Veldt, B. J., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70669 · Cited by 3
Self-citationThe unhealthy lifestyle in primary biliary cholangitis: An enemy to fight
Cossiga, V., Cazzagon, N., Montalti, R., Ciminnisi, S., Attanasio, M. R., Pezzato, F., Giacchetto, M., Guarino, M., Calvaruso, V., Floreani, A., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.12.009 · Cited by 3
Self-citationCurrent and future opportunities for the management of primary biliary cholangitis
Naffouj, S., & Wang, J. R. (2023) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2023.1241901 · Cited by 5
Gerussi, A., Nofit, E., Bernasconi, D. P., Kroll, C., Groß, F., Schregel, I., Marini, A., Cristoferi, L., Malinverno, F., Papp, M., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70134 · Cited by 3
Self-citationNoninvasive evaluation of fibrosis in adult biliary diseases
Helgadóttir, H., & Vesterhus, M. N. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000909 · Cited by 3
Wang, H., Li, Y., Pu, X., Liang, X. S., Tang, R., & Ma, X. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02045-z · Cited by 3
Cançado, G. G. L., Gomes, N. M. D. F., Couto, C. A., Cançado, E. L. R., Terrabuio, D. R. B., Villela‐Nogueira, C. A., Braga, M. H., Nardelli, M. J., Faria, L. C., Oliveira, E. M. G., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002744 · Cited by 3
Primary biliary cholangitis: personalized medicine for optimal therapeutic opportunities
Shang, Y., Leung, P. S. C., Gershwin, M. E., & Han, Y. (2022) · 中国科学通报：英文版 · doi:10.1016/j.scib.2022.11.029 · Cited by 3
Wiegand, J., Franke, A., Stein, K., Trautwein, C., & Berg, T. (2023) · Hepatology · doi:10.1097/hep.0000000000000744 · Cited by 3
Corpechot, C., Lemoinne, S., Soret, P., Chazouillères, O., & de Lédinghen, V. (2023) · Hepatology · doi:10.1097/hep.0000000000000746 · Cited by 3
Self-citationChen, J., Hou, Y., Liu, Y., Jiang, Y., & Wang, X. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i41.111256 · Cited by 2
Maxwell, M., Deng, Y., Chen, B., Silveira, M. G., Boyer, J. L., & Assis, D. N. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70574 · Cited by 2
AI in the Prediction of Hepatic Fibrosis Progression Using Non-Coding RNAs
Roy, D., Hussain, M. S., Khan, Y., Patel, D. N., Smerat, A., Bainsal, N., Ashique, S., Kumar, D. A., Khan, I. A., Ochilova, D., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120973 · Cited by 2
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Self-citationPrognostic modeling in biliary diseases
Ciobanu, C., & Russo, M. W. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000911 · Cited by 2
Mechanical mechanics-reclaiming a new battlefield for chronic liver disease
Zhang, Y., Ma, T., Lu, X., Hua, H., Wu, L., & Chen, Z. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.028 · Cited by 3
Rigamonti, C., Benedittis, C. D., Labanca, S., Vanni, E., Morgando, A., Manfredi, G. F., Azzolina, D., Cittone, M. G., Giannini, E. G., Saracco, G. M., et al. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002582 · Cited by 2
Self-citationUltrasound imaging findings in primary biliary cholangitis
Zhang, Y., Hu, X., Chang, J. K., Li, W., Huang, C., Zhang, H., Shen, J., Shang, N., & Meng, F. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-03083-w · Cited by 2
Ritter, T. E., Hanson, C., Fernandes, C. T., MacEwan, J. P., Zhao, X., Parzynski, C. S., Mercer, D., Ness, E., Wheeler, D., Kowdley, K. V., et al. (2025) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2024-0198 · Cited by 1
Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision
Choi, G., Jesudian, A. B., & Saab, S. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09537-3 · Cited by 1
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 2
Stein, K., Hofmann, W. P., Franke, A., Petroff, D., Müller, T., Bantel, H., Günther, R., Denk, G., Reuken, P. A., Schattenberg, J. M., et al. (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2721-1160 · Cited by 1
Self-citationWilliams, E. E., Lammert, C. S., & Vuppalanchi, R. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09672-5 · Cited by 1
Barrio, M. D., Sala, M., Gómez, J., Horta, D., Hernández‐Guerra, M., Salcedo, M., Goñi, S., León, R. R., Herreros, Á. M., Santiago, J. M. G., et al. (2026) · Liver International · doi:10.1111/liv.70713 · Cited by 1
Bowlus, C. L., Nevens, F., Kowdley, K. V., Bonder, A., Capozza, T. A., Li, J., Nair, R., Trauner, M. A., & Jones, D. E. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70832 · Cited by 1
Self-citationChazouillères, O., Bellet, J., Schramm, C., Trivedi, P., Thorburn, D., Färkkilä, M., Floreani, A., Pares, A., Levy, C., Beuers, U., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.07.019 · Cited by 1
Self-citationCamilleri, M., & Ford, A. C. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18527 · Cited by 1
Ding, D., Jia, G., Guo, G., Cui, L., & Han, Y. (2025) · Hepatology International · doi:10.1007/s12072-025-10820-8 · Cited by 1
Kugiyama, Y., Abe, M., Namisaki, T., Yoshiji, H., Abe, K., Ohira, H., Shirahashi, R., Yokoyama, K., Fukunaga, A., Kawata, K., et al. (2025) · Hepatology Research · doi:10.1111/hepr.70035 · Cited by 1
Va, I., & Goncharov, A. A. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i8.115416 · Cited by 1
Diagnostik- und Therapieleitfaden 2023 für PBC in Österreich
Peck‐Radosavljevic, M., Aigner, E. S., Ferlitsch, A., Graziadei, I. W., Gschwantler, M., Halilbasic, E., Hametner‐Schreil, S., Putz‐Bankuti, C., & Reiberger, T. (2023) · Journal für Gastroenterologische und Hepatologische Erkrankungen · doi:10.1007/s41971-023-00151-6
Yao, D.-W., Jiang, H.-X., & Qin, S. (2024) · Hepatitis Monthly · doi:10.5812/hepatmon-138304
Roberts, E. (2024) · EMJ Hepatology · doi:10.33590/emjhepatol/pgqp6795
Khakoo, N. S., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00039-4
Li, Z., Zhang, F., Lu, W., Lü, C., Yuan, Z., & Wang, Z. (2025) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/0115734056379090250611073434
Neue Standards in der Behandlung der primären biliären Cholangitis
Vögelin, M., & Kremer, A. E. (2025) · Schweizer Gastroenterologie · doi:10.1007/s43472-025-00173-w
Self-citation
Metadata
- Authors
- Corpechot, C., Carrat, F., Gaouar, F., Chau, F., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Schramm, C., Pares, A., Olivas, I., Eaton, J. E., Osman, K. T., Dalekos, G., Gatselis, N., Nevens, F., Cazzagon, N., Zago, A., Russo, F. P., Abbas, N., Trivedi, P., Thorburn, D., Saffioti, F., Barkai, L., Roccarina, D., Calvaruso, V., Fichera, A., Delamarre, A., Medina-Morales, E., Bonder, A., Patwardhan, V., Rigamonti, C., Carbone, M., Invernizzi, P., Cristoferi, L., van der Meer, A., de Veer, R., Zigmond, E., Yehezkel, E., Kremer, A. E., Deibel, A., Dumortier, J., Bruns, T., Große, K., Pageaux, G.-P., Wetten, A., Dyson, J., Jones, D., Chazouillères, O., Hansen, B., & de Lédinghen, V.
- Affiliations
- Inserm (FR)
- Sorbonne Université (FR)
- University Health Network (CA)
- University of Alberta (CA)
- Universität Hamburg (DE)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Mayo Clinic (US)
- University Hospital of Larissa (GR)
- Universitair Ziekenhuis Leuven (BE)
- University of Padua (IT)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- The Royal Free Hospital (GB)
- University of Palermo (IT)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Beth Israel Deaconess Medical Center (US)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Milano-Bicocca (IT)
- Erasmus MC (NL)
- Tel Aviv Sourasky Medical Center (IL)
- University Hospital Zurich (CH)
- Hospices Civils de Lyon (FR)
- Universitätsklinikum Aachen (DE)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Newcastle upon Tyne Hospital (GB)
- Corresponding author
- Corpechot, Christophe
- ORCID
- Corpechot, Christophe
- Carrat, Fabrice
- Hirschfield, Gideon
- Gulamhusein, Aliya
- Lytvyak, Ellina
- Schramm, Christoph
- Pares, Albert
- Olivas, Ignasi
- Eaton, John E.
- Osman, Karim T.
- Dalekos, George
- Gatselis, Nikolaos
- Nevens, Frederik
- Cazzagon, Nora
- Zago, Alessandra
- Russo, Francesco Paolo
- Abbas, Nadir
- Trivedi, Palak
- Thorburn, Douglas
- Saffioti, Francesca
- Roccarina, Davide
- Delamarre, Adèle
- Medina-Morales, Esli
- Bonder, Alan
- Patwardhan, Vilas
- Rigamonti, Cristina
- Carbone, Marco
- Invernizzi, Pietro
- Cristoferi, Laura
- van der Meer, Adriaan
- Zigmond, Ehud
- Yehezkel, Eyal
- Kremer, Andreas E.
- Deibel, Ansgar
- Dumortier, Jérôme
- Bruns, Tony
- Große, Karsten
- Pageaux, Georges-Philippe
- Wetten, Aaron
- Dyson, Jessica
- Chazouillères, Olivier
- de Lédinghen, Victor
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 77
- Issue
- 6
- Pages
- 1545-1553
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4283645165
- Cited by
- 128
- References
- 40
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 27 · 2023: 25 · 2022: 6
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Hepatology (acceptedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc-nd)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Falk Foundation
- GlaxoSmithKline
- Inventiva Pharma
- National Institute for Health and Care Research (NIHR200243, NF-SI-0513-10091)
- Swedish Orphan Biovitrum
- Grifols
- Medical Research Council (MR/L001489/1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, liver stiffness measurement, vibration-controlled transient elastography, prognosis, liver complications, liver transplantation, mortality, liver fibrosis, surrogate endpoints, risk stratification, cut-off values, prognostic validation, fibrosis score, autoimmune liver disease, time-dependent Cox regression, concordance index
- MeSH terms
- Follow-Up Studies, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis, Biliary, Prognosis, Retrospective Studies, Vibration, Cohort Studies, Elasticity Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
